Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Search

Total 24 results found. Search for [ D G Shah ]

Results 1 to 21 of 24
BusinessToday.In
New Delhi, September 24, 2018
The engagement ceremony of Isha Ambani and Anand Piramal began on Friday and ended on Sunday with a farewell lunch.


E Kumar Sharma
New Delhi, January 12, 2018
Many companies, with some leading players, are already coping with challenges around price erosion in generics, erosion of base business resulting from new competition and buyer consolidation in their biggest global market, the US.


PTI
December 27, 2017



E Kumar Sharma
New Delhi, November 12, 2017
Every business has the right to adopt legitimate practises to protect their own interest. Right? But a recent article argues that going beyond the patent act, which permits research and development during the life of a patent, some innovator drug companies are busy trying to block this.


E Kumar Sharma
New Delhi, November 6, 2017
Why should there be the Goods and Services Tax on materials that cannot be sold? That is the question, the Indian pharmaceutical industry, is hoping will get addressed in the final tweaking of the GST provisions.


E Kumar Sharma
New Delhi, October 24, 2017
On October 20th the ministry of chemicals and fertilizers issued a press note in what seems an attempt to allay industry fears on the issue of price controls.


E.Kumar Sharma
March 2, 2017
What is the 'right price' for a medicine? This is a matter of constant debate and the response, as you would expect, pretty much depends on the economic background of the person answering the question.


E Kumar Sharma
February 28, 2017
These include drugs from some of the leading pharmaceutical companies like Sun Pharma, Cipla, Dr Reddy's, Alembic, Abbott Healthcare, GlaxoSmithKline among others.


E Kumar Sharma
New Delhi, February 1, 2017
The Indian pharmaceutical industry has for the past couple of years complained that it tends to get more or less ignored in the budget, and though there were references to the sector this time, not many see them as  bold or hugely impactful or transformational.


E Kumar Sharma
June 3, 2016
\"Real, meaningful progress remains elusive, and recent signals indicate backsliding in key areas. For instance, India just released its long-awaited National Intellectual Property Rights Policy, which falls far short of industry expectations.\"


E Kumar Sharma
May 15, 2016
Some are not sure if the amendments in the policy that are being proposed are being done without an amendment to the Patent Act but through a notification on amendment of rules. There is still need for clarity on this.


E Kumar Sharma
February 26, 2016
Reeling under the regulatory glare, some of India's leading pharma companies, who have been pulled up by the US regulator on matters around good manufacturing practices and drug quality standards, seem ready and eager to get the US drug regulator and the Indian drug authorities on the same page over these matters.


Venkatesha Babu
August 14, 2015
The central government's Make in India initiative and a spurt in interest shown by angel investors and venture capitalists to fund tech hardware start-ups might just give the much-needed boost to the industry.


PTI
New Delhi, April 8, 2015
The government has allowed pharmaceutical companies to hike rates of 509 essential medicines used for treating various ailments like diabetes, hepatitis and cancer by 3.84 per cent with effect from April 1.


M. G. Arun and Ganesh N
Mumbai, May 9, 2014
Jignesh Shah, chairman and chief executive officer (CEO) of Financial Technologies (India) Limited (FTIL) was remanded in police custody by the Maharashtra Protection of Interest of Depositors court till May 15 on Thursday.


E. Kumar Sharma
May 2, 2014
Indian pharma industry has been alleging that there is a strong lobby group of multinational companies at work in the US keen to ensure that India is downgraded from the priority watch list to \"priority foreign country\" , as is the case with Ukraine at the moment.


BT Online Bureau
New Delhi, August 23, 2013
National Spot Exchange (NSEL) has declared nine members (buyers) who failed to pay their dues on the first day of settlement on August 20 as 'defaulters'.


PTI
August 5, 2013
The National Spot Exchange Ltd (NSEL), which faces a risk of default after suspending trade, on Monday said it has formed an independent committee to advise and monitor settlement of trade amounting to about Rs 5,500 crore.


BT Online Bureau
Mumbai, August 5, 2013
FTIL's scrip had slumped 72 per cent over the last two days amid problems at group entity National Spot Exchange Ltd (NSEL).


PTI
New Delhi, December 25, 2012
A new drug price control policy, restrictions on multinationals taking over domestic firms and India cracking down on foreign firms' patents marked the year 2012 for the $22 billion pharmaceutical sector.


PAGES 1 OF 2  12